Battlefield Emergency Use Bill Faces Pushback From US FDA, Authorizing Committees
Executive Summary
Top Republicans on FDA authorizing committees worry that undermining agency's sole authority to approve drugs and devices would bring more harm than good.
You may also be interested in...
Gottlieb On Being Senate-Confirmed US FDA Commissioner: It's Certainly An Advantage
US FDA would have more influence in inter-agency turf battles, can build stronger relationships on Capitol Hill with a confirmed commissioner, Scott Gottlieb says.
Military Products Will Get US FDA Fast-Track Review
FDA and the US Department of Defense launched a program to prioritize development of medical products for use in the battlefield. The program implements recently enacted compromise legislation that resolved a turf battle between the two agencies.
US FDA Creates Expedited Review For Military-Related Products
All 'top priority' battlefield products will get FDA review by June 30; longer term plan includes draft guidance on development of products designed for use in austere conditions.